Mika K Derynck, a director at $ELVN, sold 158,795 shares of the company on 08-04-2026 for an estimated $9,561,586. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $ELVN stock.
$ELVN Insider Trading Activity
$ELVN insiders have traded $ELVN stock on the open market 42 times in the past 6 months. Of those trades, 0 have been purchases and 42 have been sales.
Here’s a breakdown of recent trading of $ELVN stock by insiders over the last 6 months:
- ADVISORS LLC ORBIMED has made 0 purchases and 6 sales selling 1,141,531 shares for an estimated $51,683,033.
- MIKA K DERYNCK sold 158,795 shares for an estimated $9,561,586
- HELEN LOUISE COLLINS (CHIEF MEDICAL OFFICER) has made 0 purchases and 19 sales selling 150,000 shares for an estimated $4,843,037.
- BENJAMIN HOHL (CHIEF FINANCIAL OFFICER) has made 0 purchases and 9 sales selling 22,036 shares for an estimated $876,196.
- LORI ANNE KUNKEL has made 0 purchases and 5 sales selling 20,000 shares for an estimated $850,254.
- JOSEPH P LYSSIKATOS (CHIEF SCIENTIFIC OFFICER) sold 5,000 shares for an estimated $145,219
- RICHARD A. HEYMAN sold 1,230 shares for an estimated $32,196
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ELVN Hedge Fund Activity
We have seen 112 institutional investors add shares of $ELVN stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BELLEVUE GROUP AG added 2,320,867 shares (+inf%) to their portfolio in Q1 2026, for an estimated $90,977,986
- FAIRMOUNT FUNDS MANAGEMENT LLC removed 1,855,800 shares (-50.0%) from their portfolio in Q1 2026, for an estimated $72,747,360
- POLAR CAPITAL HOLDINGS PLC added 1,552,253 shares (+44.2%) to their portfolio in Q1 2026, for an estimated $60,848,317
- POINT72 ASSET MANAGEMENT, L.P. removed 1,504,601 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $58,980,359
- COMMODORE CAPITAL LP removed 1,417,809 shares (-30.2%) from their portfolio in Q1 2026, for an estimated $55,578,112
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,304,346 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $51,130,363
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 794,131 shares (-77.5%) from their portfolio in Q1 2026, for an estimated $31,129,935
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ELVN Analyst Ratings
Wall Street analysts have issued reports on $ELVN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 06/09/2026
To track analyst ratings and price targets for $ELVN, check out Quiver Quantitative's $ELVN forecast page.
$ELVN Price Targets
Multiple analysts have issued price targets for $ELVN recently. We have seen 5 analysts offer price targets for $ELVN in the last 6 months, with a median target of $64.0.
Here are some recent targets:
- Robert Burns from HC Wainwright & Co. set a target price of $64.0 on 07/09/2026
- Dara Azar from Stifel set a target price of $80.0 on 07/01/2026
- Boris Peaker from Jones Trading set a target price of $70.0 on 06/29/2026
- Salim Syed from Mizuho set a target price of $62.0 on 06/02/2026
- Salveen Richter from Goldman Sachs set a target price of $59.0 on 05/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
